
	As of April 30, 2026
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Treasury bills and U.S. government securities(1)	$	608,268	$	—	$	(581)	$	607,687
Corporate bonds	138,445		—		(176)		138,269

Commercial paper	34,704		—		(12)		34,692
Yankee bonds	2,909		—		(6)		2,903

Total marketable securities	$	784,326	$	—	$	(775)	$	783,551
(1) Additional treasury bills with both amortized cost and estimated fair value of $32.0 million are included in cash and cash equivalents due to their original maturities of three months or less.


	As of January 31, 2026
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Treasury bills and U.S. government securities(1)	$	619,831	$	324	$	—	$	620,155
Corporate bonds	160,872		5		—		160,877
Commercial paper	34,373		17		—		34,390
Yankee bonds	2,899		—		(2)		2,897


Total marketable securities	$	817,975	$	346	$	(2)	$	818,319
(1) Additional treasury bills with both amortized cost and estimated fair value of $22.0 million are included in cash and cash equivalents due to their original maturities of three months or less.

As of April 30, 2026 and January 31, 2026, $108.5 million and $217.0 million, respectively, of our marketable securities had remaining contractual maturities of one year or more.

As of April 30, 2026 and January 31, 2026, $6.9 million and $10.1 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2026 or January 31, 2026.

Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.